Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 1608 for:    Pancreatic Cancer | United States

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02581501
Recruitment Status : Withdrawn (Due to no enrollment, Celgene (sponsor) withdrew funding)
First Posted : October 21, 2015
Last Update Posted : April 18, 2019
Sponsor:
Information provided by (Responsible Party):
Stamford Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016